PURE Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -69.6% | -69.6% | -53.9% |
| FY2022 | -89.3% | -89.3% | -77.9% |
| FY2023 | -1,456.3% | -1,456.3% | -217.0% |
| FY2024 | 117.0% | 117.0% | -409.5% |
| FY2025 | 46.9% | 46.9% | -226.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -69.6% | -69.6% | -53.9% |
| FY2022 | -89.3% | -89.3% | -77.9% |
| FY2023 | -1,456.3% | -1,456.3% | -217.0% |
| FY2024 | 117.0% | 117.0% | -409.5% |
| FY2025 | 46.9% | 46.9% | -226.7% |